Modeling a Nociceptive Neuro-Immune Synapse Activated by ATP and 5-HT in Meninges: Novel Clues on Transduction of Chemical Signals Into Persistent or Rhythmic Neuronal Firing.

5-HT ATP mast cells migraine model trigeminal nerve

Journal

Frontiers in cellular neuroscience
ISSN: 1662-5102
Titre abrégé: Front Cell Neurosci
Pays: Switzerland
ID NLM: 101477935

Informations de publication

Date de publication:
2020
Historique:
received: 02 03 2020
accepted: 22 04 2020
entrez: 9 6 2020
pubmed: 9 6 2020
medline: 9 6 2020
Statut: epublish

Résumé

Extracellular ATP and serotonin (5-HT) are powerful triggers of nociceptive firing in the meninges, a process supporting headache and whose cellular mechanisms are incompletely understood. The current study aimed to develop, with the neurosimulator NEURON, a novel approach to explore in silico the molecular determinants of the long-lasting, pulsatile nature of migraine attacks. The present model included ATP and 5-HT release, ATP diffusion and hydrolysis, 5-HT uptake, differential activation of ATP P2X or 5-HT3 receptors, and receptor subtype-specific desensitization. The model also tested the role of branched meningeal fibers with multiple release sites. Spike generation and propagation were simulated using variable contribution by potassium and sodium channels in a multi-compartment fiber environment. Multiple factors appeared important to ensure prolonged nociceptive firing potentially relevant to long-lasting pain. Crucial roles were observed in: (i) co-expression of ATP P2X2 and P2X3 receptor subunits; (ii) intrinsic activation/inactivation properties of sodium Nav1.8 channels; and (iii) temporal and spatial distribution of ATP/5-HT release sites along the branches of trigeminal nerve fibers. Based on these factors we could obtain either persistent activation of nociceptive firing or its periodic bursting mimicking the pulsating nature of pain. In summary, our model proposes a novel tool for the exploration of peripheral nociception to test the contribution of clinically relevant factors to headache including migraine pain.

Identifiants

pubmed: 32508598
doi: 10.3389/fncel.2020.00135
pmc: PMC7248338
doi:

Types de publication

Journal Article

Langues

eng

Pagination

135

Informations de copyright

Copyright © 2020 Suleimanova, Talanov, Gafurov, Gafarov, Koroleva, Virenque, Noe, Mikhailov, Nistri and Giniatullin.

Références

J Neurosci. 2007 Aug 1;27(31):8190-201
pubmed: 17670966
J Neurosci. 2012 Aug 22;32(34):11890-6
pubmed: 22915129
J Neurosci. 2016 Feb 24;36(8):2364-76
pubmed: 26911685
Front Cell Neurosci. 2015 Jul 28;9:287
pubmed: 26283923
J Comp Neurol. 2004 May 31;473(3):364-76
pubmed: 15116396
Ann Biomed Eng. 2001 Sep;29(9):740-51
pubmed: 11599582
Ann Neurol. 2010 May;67(5):680-3
pubmed: 20437566
J Neurosci. 2004 May 19;24(20):4709-17
pubmed: 15152030
J Neurophysiol. 2015 May 1;113(9):3172-85
pubmed: 25787950
Mol Pharmacol. 2006 Jul;70(1):373-82
pubmed: 16627751
J Neurosci. 2004 Dec 8;24(49):11046-56
pubmed: 15590921
Physiol Res. 2012;61(1):113-24
pubmed: 21574765
Expert Opin Ther Targets. 2003 Aug;7(4):513-22
pubmed: 12885270
Purinergic Signal. 2007 Sep;3(4):269-84
pubmed: 18404441
J Pharmacol Exp Ther. 2017 Jun;361(3):472-481
pubmed: 28404687
Brain Res Bull. 2001 Mar 15;54(5):507-12
pubmed: 11397540
Lancet. 1981 Jun 27;1(8235):1397-9
pubmed: 6113355
AJNR Am J Neuroradiol. 2002 Feb;23(2):194-9
pubmed: 11847041
Br J Anaesth. 2000 Apr;84(4):476-88
pubmed: 10823099
Exp Brain Res. 2009 Jun;196(1):179-93
pubmed: 19288089
Br J Pharmacol. 2007 May;151(2):226-36
pubmed: 17351651
Front Pharmacol. 2018 Apr 24;9:420
pubmed: 29740328
Pflugers Arch. 2008 May;456(2):339-47
pubmed: 18026985
Int J Numer Method Biomed Eng. 2013 Oct;29(10):1038-56
pubmed: 23894050
Headache. 2014 Jun;54(6):996-1009
pubmed: 24673461
J Neurosci. 2015 Dec 2;35(48):15984-95
pubmed: 26631478
Front Cell Neurosci. 2019 Apr 05;13:136
pubmed: 31024263
Handb Exp Pharmacol. 2017;241:121-139
pubmed: 28332048
Biophys J. 2009 Sep 2;97(5):1335-45
pubmed: 19720021
J Theor Biol. 2005 Jun 7;234(3):363-82
pubmed: 15784271
Neuropharmacology. 2017 Apr;116:160-173
pubmed: 28025094
Pain. 2007 Jul;130(1-2):166-76
pubmed: 17459586
J Neurophysiol. 2014 May;111(9):1721-35
pubmed: 24371290
Front Cell Neurosci. 2019 Feb 13;13:45
pubmed: 30814932
Front Cell Neurosci. 2019 May 10;13:195
pubmed: 31133812
Pflugers Arch. 2006 Dec;453(3):353-60
pubmed: 16741755
Front Cell Neurosci. 2013 Dec 06;7:245
pubmed: 24367291
J Physiol. 2019 Jul;597(14):3751-3768
pubmed: 31087362
Cell Biochem Funct. 2014 Jan;32(1):70-6
pubmed: 23584980
Annu Rev Physiol. 2013;75:365-91
pubmed: 23190076
Nat Rev Drug Discov. 2008 Jul;7(7):575-90
pubmed: 18591979
Neuron Glia Biol. 2010 Feb;6(1):31-42
pubmed: 20604978
Br J Pharmacol. 2019 Jul;176(13):2279-2291
pubmed: 30927255
J Neurosci. 2010 Jun 9;30(23):7878-88
pubmed: 20534836
Evid Based Complement Alternat Med. 2013;2013:350949
pubmed: 23861703
Nature. 2000 Oct 26;407(6807):1011-5
pubmed: 11069181
J Neurochem. 2014 Aug;130(3):351-9
pubmed: 24702305
PLoS Comput Biol. 2017 Sep 1;13(9):e1005737
pubmed: 28863150
J Neurophysiol. 2011 Dec;106(6):3173-84
pubmed: 21940606
Continuum (Minneap Minn). 2018 Aug;24(4, Headache):1009-1022
pubmed: 30074546
J Neurosci. 2001 Aug 15;21(16):5952-61
pubmed: 11487618
Immunol Rev. 2007 Jun;217:65-78
pubmed: 17498052
J Neurosci Methods. 2005 Apr 15;143(1):49-62
pubmed: 15763136
Headache. 2018 May;58 Suppl 1:4-16
pubmed: 29697154
Pharmacol Ther. 2012 Dec;136(3):319-33
pubmed: 22939884
J Neurosci. 2005 Aug 10;25(32):7359-65
pubmed: 16093386
Nature. 1995 Oct 5;377(6548):428-31
pubmed: 7566119
Int Arch Allergy Immunol. 2003 Jun;131(2):80-4
pubmed: 12811015
Int J Mol Sci. 2020 Jan 21;21(3):
pubmed: 31973098
Nat Rev Neurosci. 2006 Jun;7(6):423-36
pubmed: 16715052
Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):8063-7
pubmed: 8755603
Science. 2013 Mar 1;339(6123):1092-5
pubmed: 23449592
PLoS Comput Biol. 2018 Jul 18;14(7):e1006293
pubmed: 30020934
Neurochem Res. 2001 Sep;26(8-9):959-69
pubmed: 11699948
Cephalalgia. 2017 Jan;37(1):36-48
pubmed: 26970607
Lancet Neurol. 2009 Jul;8(7):679-90
pubmed: 19539239
J Gen Physiol. 2003 Jul;122(1):33-44
pubmed: 12810852
J Gen Physiol. 2007 Aug;130(2):183-201
pubmed: 17664346
Front Cell Neurosci. 2019 Dec 03;13:521
pubmed: 31849611
J Neurosci. 2006 Jun 7;26(23):6163-71
pubmed: 16763024
J Biol Chem. 2017 Jun 2;292(22):9262-9272
pubmed: 28381558
Mol Pain. 2006 Mar 28;2:11
pubmed: 16566843
Neural Comput. 1997 Aug 15;9(6):1179-209
pubmed: 9248061
Mol Pain. 2016 Mar 29;12:
pubmed: 27030723
J Clin Invest. 2016 Dec 1;126(12):4527-4536
pubmed: 27797339
Pharmacol Ther. 2006 Jun;110(3):433-54
pubmed: 16226312
Neuropharmacology. 2019 May 1;149:113-123
pubmed: 30768945
Front Neurol. 2017 Apr 27;8:163
pubmed: 28496430
Nature. 1995 Oct 5;377(6548):432-5
pubmed: 7566120
Nature. 2000 Oct 26;407(6807):1015-7
pubmed: 11069182
Purinergic Signal. 2016 Sep;12(3):561-74
pubmed: 27369815
Neurol Sci. 2015 Apr;36(4):535-40
pubmed: 25417066
J Physiol. 2004 Jan 15;554(Pt 2):301-8
pubmed: 12832496

Auteurs

Alina Suleimanova (A)

Laboratory of Neurobiology, Kazan Federal University, Kazan, Russia.

Max Talanov (M)

Laboratory of Neurobiology, Kazan Federal University, Kazan, Russia.

Oleg Gafurov (O)

Laboratory of Neurobiology, Kazan Federal University, Kazan, Russia.

Fail' Gafarov (F)

Laboratory of Neurobiology, Kazan Federal University, Kazan, Russia.

Ksenia Koroleva (K)

Laboratory of Neurobiology, Kazan Federal University, Kazan, Russia.

Anaïs Virenque (A)

Neuroscience Center, Helsinki University, Helsinki, Finland.

Francesco M Noe (FM)

Neuroscience Center, Helsinki University, Helsinki, Finland.

Nikita Mikhailov (N)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

Andrea Nistri (A)

Department of Neuroscience, International School for Advanced Studies, Trieste, Italy.

Rashid Giniatullin (R)

Laboratory of Neurobiology, Kazan Federal University, Kazan, Russia.
A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

Classifications MeSH